Search

 Trial will assess the safety and efficacy of iadademstat in pulmonary and extrapulmonary NECs

NIMBLE Diagnostics, ha cerrado con éxito una ronda de financiación donde han conseguido más un millón de euros liderada por Grow Ventures junto con Namarel Ventures e Inveniam Group

Barcelona, the leader in the biotechnology and life sciences sector in Spain, will host this edition from 26 to 28 September, which is the 20th anniversary of the event.

The spin-off of IRB Barcelona, the UB and SJD has a patented technology based on peptides (small proteins) that efficiently cross biological barriers, such as the blood-brain barrier that protects the

One of the key challenges in the process of developing new bioproducts is to overcome the transition period in which a technology under development is envisaged as promising

BCN HEALTH ha publicado el estudio Hospital Incidence and Medical Costs of Female Breast Cancer in Spain: A Retrospective Multicenter Study ' en la revista 'Current Cancer Therapy Reviews'

The science and technology company Merck has awarded the Merck Chair Award to the best works of the Master's Degree in Management of Biotechnology Companies in Health

R&D is at the heart of Almirall's strategy